TriMas Life Sciences names Jim Kepler as VP and GM; Kepler joined TriMas in 2022 through its acquisition of Intertech

Sample article from our Health Care Sector

BLOOMFIELD HILLS, Michigan , May 6, 2024 (press release) –

Download Press Release 

TriMas (NASDAQ: TRS) today announced that Jim Kepler has been appointed to Vice President and General Manager of TriMas’ Life Sciences group, effective April 29, 2024. In this position, Jim will report directly to Fabio Salik, President, TriMas Packaging.

As Vice President and General Manager of TriMas' Life Sciences group, Jim will assume full P&L responsibility for the division. Leading the Life Sciences team, Jim will focus on driving profitable sales growth, operational excellence, M&A activities and new product innovations.

Jim became part of TriMas in 2022 through its acquisition of Intertech. Over his 25-year tenure, he has steered Intertech's growth into Colorado's largest injection molding manufacturer, particularly prominent in the medical device industry. Jim's leadership has been pivotal in achieving this success, emphasizing the development of high-performing teams and the adoption of cutting-edge technologies, such as highly automated quality compliance and manufacturing systems. In addition to his focus on organizational success, Jim has made substantial investments in developing top talent and educational initiatives. He actively promotes manufacturing awareness in STEM programs within the Denver Public School district and is deeply involved in implementing CareerWise, a nationally recognized apprenticeship program.

About TriMas
TriMas manufactures a diverse set of products primarily for the consumer products, aerospace and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. Our approximately 3,400 dedicated employees in 13 countries provide customers with a wide range of innovative and quality product solutions through our market-leading businesses. Our TriMas family of businesses has strong brand names in the markets served, and operates under a common set of values and strategic priorities under the TriMas Business Model. TriMas is publicly traded on the NASDAQ under the ticker symbol “TRS,” and is headquartered in Bloomfield Hills, Michigan. For more information, please visit www.trimas.com.

Contact
Sherry Lauderback
VP, Investor Relations & Communications
(248) 631-5506
Sherry.lauderback@trimas.com

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.